Curtis Gale Oltmans

Insider Reports History

Entity
Individual
Location
C/O Array Biopharma Inc., 3200 Walnut St., Boulder, CO
Signature
/s/ David Jin, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Curtis Gale Oltmans:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Fulcrum Therapeutics, Inc. Chief Legal Officer Stock Option (right to buy) 150K Jan 26, 2024 Direct
AVENUE THERAPEUTICS, INC. Director Employee stock option (right to buy) 30K Sep 23, 2024 Direct

Insider Reports Filed by Curtis Gale Oltmans

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATXI AVENUE THERAPEUTICS, INC. Sep 23, 2024 1 $0 4 Sep 25, 2024 Director
FULC Fulcrum Therapeutics, Inc. Jan 26, 2024 1 $0 4 Jan 30, 2024 Chief Legal Officer
ATXI AVENUE THERAPEUTICS, INC. Jun 30, 2023 1 $0 4 Jul 5, 2023 Director
FULC Fulcrum Therapeutics, Inc. Apr 26, 2023 1 $0 4 Apr 28, 2023 Chief Legal Officer
FULC Fulcrum Therapeutics, Inc. Feb 9, 2023 1 $0 4 Feb 13, 2023 Chief Legal Officer
FULC Fulcrum Therapeutics, Inc. Aug 9, 2022 1 $0 4 Aug 11, 2022 Chief Legal Officer
FULC Fulcrum Therapeutics, Inc. Jan 19, 2022 1 $0 4 Jan 21, 2022 SVP, General Counsel
FULC Fulcrum Therapeutics, Inc. Dec 31, 2021 1 $0 5 Jan 7, 2022 SVP, General Counsel
ATXI AVENUE THERAPEUTICS, INC. Dec 17, 2021 1 $0 4 Dec 21, 2021 Director
FULC Fulcrum Therapeutics, Inc. Jun 28, 2021 1 $9.8K 4 Jun 29, 2021 SVP, General Counsel
ATXI AVENUE THERAPEUTICS, INC. Apr 1, 2021 0 $0 3 Dec 21, 2021 Director